Caesappanin CCAS# 1913319-59-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1913319-59-1 | SDF | Download SDF |
PubChem ID | 101881655 | Appearance | Powder |
Formula | C32H32O10 | M.Wt | 576.59 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | C1C2=CC(=C(C=C2C3=C(CC(CC4=CC(=C(C=C4C5=C(CC1(CO)O)C=C(C=C5)O)O)O)(CO)O)C=C(C=C3)O)O)O | ||
Standard InChIKey | USVPAMXDEQJWJM-MEKGRNQZSA-N | ||
Standard InChI | InChI=1S/C32H32O10/c33-15-31(41)11-17-5-21(35)1-3-23(17)25-9-29(39)27(37)7-19(25)13-32(42,16-34)12-18-6-22(36)2-4-24(18)26-10-30(40)28(38)8-20(26)14-31/h1-10,33-42H,11-16H2/t31-,32+ | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Caesappanin C exhibits a proliferation stimulating activity against primary osteoblastic cells. |
Caesappanin C Dilution Calculator
Caesappanin C Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.7343 mL | 8.6717 mL | 17.3433 mL | 34.6867 mL | 43.3584 mL |
5 mM | 0.3469 mL | 1.7343 mL | 3.4687 mL | 6.9373 mL | 8.6717 mL |
10 mM | 0.1734 mL | 0.8672 mL | 1.7343 mL | 3.4687 mL | 4.3358 mL |
50 mM | 0.0347 mL | 0.1734 mL | 0.3469 mL | 0.6937 mL | 0.8672 mL |
100 mM | 0.0173 mL | 0.0867 mL | 0.1734 mL | 0.3469 mL | 0.4336 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Myrrhone
Catalog No.:BCN8642
CAS No.:183551-83-9
- Lancifodilactone C
Catalog No.:BCN8641
CAS No.:663176-26-9
- Hypaconine
Catalog No.:BCN8640
CAS No.:63238-68-6
- Glabrone
Catalog No.:BCN8639
CAS No.:60008-02-8
- Bruceoside A
Catalog No.:BCN8638
CAS No.:63306-30-9
- Veratrosine
Catalog No.:BCN8637
CAS No.:475-00-3
- (Z)-Aldosecologanin
Catalog No.:BCN8636
CAS No.:82474-97-3
- Dihydrolicoisoflavone
Catalog No.:BCN8635
CAS No.:164163-92-2
- Kushenol S
Catalog No.:BCN8634
CAS No.:254886-72-1
- 2,3,4,5-Tetracaffeoyl-D-glucaric acid
Catalog No.:BCN8633
CAS No.:1419478-52-6
- Saikosaponin E
Catalog No.:BCN8632
CAS No.:64340-44-9
- 2-Amino-N-(2-bromophenyl)benzamide
Catalog No.:BCN8631
CAS No.:34489-85-5
- (1S,2S)-threo-Honokitriol
Catalog No.:BCN8644
CAS No.:1099687-80-5
- 1''-O-beta-D-glucopyranosylformoside
Catalog No.:BCN8645
CAS No.:148245-77-6
- 14,15beta-Dihydroxyklaineanone
Catalog No.:BCN8646
CAS No.:137359-82-1
- Nephthenol
Catalog No.:BCN8647
CAS No.:53915-41-6
- Bryodulcosigenin
Catalog No.:BCN8648
CAS No.:4965-97-3
- Euphorbia factor L7b
Catalog No.:BCN8649
CAS No.:93550-95-9
- Nortracheloside
Catalog No.:BCN8650
CAS No.:33464-78-7
- 1-Methyl-6-oxopyridine-3-carboxylic acid
Catalog No.:BCN8651
CAS No.:3719-45-7
- Daidzein diacetate
Catalog No.:BCN8652
CAS No.:3682-01-7
- 11alpha-Methoxysaikosaponin F
Catalog No.:BCN8653
CAS No.:104109-37-7
- Angelicolide
Catalog No.:BCN8654
CAS No.:90826-58-7
- 5-Ethoxy-10-Gingerol
Catalog No.:BCN8655
CAS No.:121771-98-0
Phytochemical investigation of the active constituents from Caesalpinia sappan on stimulation of osteoblastic cells.
Plant Tissue Culture Letters, 2014, 31(5):505-509.
Heartwood of Caesalpinia sappan L. has been traditionally used to many diseases such as homoptysis, syphilis, eye disease, dysentery, depurative and prevention of osteoporosis. Our previous in vitro screening of Indonesian plants revealed that an ethanolic extract of the heartwood of C. sappan exhibits a proliferation stimulating activity against primary osteoblastic cells. In our continued interest to this plant, we further fractionated the extract and isolated active constituents on the basis of the stimulating activity in the osteoblastic cells. The fractionation and isolation were carried out with various chromatography methods and the structure of isolated compounds was elucidated based on NMR, IR, UV and MS spectroscopic data. From an active fraction, a new biphenyl dimer, namely Caesappanin C (1), along with two known compounds, protosappanin A (2) and sappanchalcone (3), were isolated. Among them, the new compound 1 exhibited the strongest activity and significantly increased the cell viability up to 276 +/- 5%. The other two compounds 2 and 3 also stimulated the cell proliferation and increased the cell viability up to 233 +/- 8% and 187 +/- 4%, respectively.